Used in cancer immunotherapy to block the PD-L1 protein, which helps cancer cells evade the immune system. By inhibiting PD-L1, it enhances the body's immune response against tumors, making it effective in treating various cancers like lung, bladder, and melanoma. It is often employed in combination with other therapies to improve treatment outcomes. Research also explores its potential in autoimmune diseases by modulating immune activity.